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Abstract
Objective: Determining the effectiveness of iniltration versus instillation with 7.5% ropivacaine 
in reducing the intensity of postoperative pain in patients undergoing a radical mastectomy. 
Material and methods: Clinical, prospective, and comparative analytical study in a sample of 20 
female patients between 20 and 60 years of age, ASA I and II, weight 50-90 kg, who were divided 
into 2 groups (10 patients each). In Group 1 infiltration with ropivacaine 7.5% (20 ml) was 
applied prior to closure of the surgical wound, meanwhile in Group 2 ropivacaine 7.5% (20 ml), 
was instilled into the surgical wound. Pain intensity was assessed by a visual analog scale (VAS) 
upon extubation. The need for rescue medication and the incidence of nausea and vomiting 
were measured from 0 to 30 minutes postoperatively and at 2, 4, 8 and 12 hours. 
Results: There was no statistical difference between the groups (only the group managed 
through iniltration required rescue medications), but the iniltration group had a lower percep-
tion of pain. 
Conclusions: This study reported the same eficacy of preventive treatment of postoperative 
pain in patients who underwent radical mastectomy for instillation and iniltration with 7.5% 
ropivacaine and little need for rescue medication postoperatively.
1665-5796 © 2014 Revista Medicina Universitaria. Facultad de Medicina UANL. Publicado por Elsevier México. Todos 
los derechos reservados.
Introduction
Preventive analgesia was described by Crile in 1913 as an op-
tion to prevent alterations in the autonomic nervous system 
resulting from postoperative pain, based in regional blocks 
with local and general anesthetics.1 Initially, preventive 
analgesia for postoperative pain treatment was not well ac-
cepted, due to controversial results in experimental and 
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clinical research work; however, nowadays its use is being 
reconsidered.2-5
Underestimated postoperative pain by medical personnel 
as well as lack of knowledge and adherence to a multimodal 
analgesic management, are factors accounting for an inade-
quate therapeutic management of postoperative patients. 
This has a direct impact on the patient’s optimal recovery, 
in addition to allowing the development of chronic compli-
cations following the surgical procedure. Studies published 
in recent years show a prevalence of moderate to unbeara-
ble pain of 11% (in a hospital with an acute postoperative 
pain unit), and in 70% of the patients who have undergone 
surgery during the irst 24 to 48 hours; nevertheless, preva-
lence has always exceeded 30%.6 
There are surgical procedures such as mastectomies in 
women, which besides producing pain may cause diverse 
emotional reactions.7 Breast cancer is one of the 2 most 
common malignancies in women worldwide and the main 
treatment for this pathology is surgery.7-10
Despite different therapeutic approaches with several 
analgesics and routes of administration to avoid pain, the 
desired analgesic effect is not accomplished in some pa-
tients; a reason for this could be the route of administration 
used or the fact that the strength of the medication may be 
insuficient. 
Radical mastectomy is an extensive and disiguring proce-
dure, which causes acute postoperative pain due to soft tis-
sue injury of the anterior wall of the thorax. During 
dissection, tissue traction takes place producing damage to 
the axons of the intercostal nerves and brachial plexus emer-
gence. There are several anesthetic strategies; some of the 
most commonly utilized are intercostal nerve blocks, preope-
rative thoracic epidural block, thoracic paravertebral block, 
local iniltration blocks, and direct instillation.11-13
Instillation is the introduction of a liquid (by pouring or 
injection), drop by drop over mucous membranes or the 
skin. It is a very commonly used method. Postoperative inil-
tration (direct administration of the analgesic into the sur-
gical area), as a strategy for pain management in this 
pathology has not been studied extensively and is undercon-
sidered regarding patient management, hence this study. 
We carried out a comparison between these 2 local analge-
sic administration techniques by means of a pain scale and 
the use of rescue medication; by doing so, we attempted to 
decrease the endocrine response caused by pain and the 
side effects in the cardiopulmonary and immunology 
functions that patients with postoperative pain suffer.14 
Material and methods
We included female patients scheduled for radical mastec-
tomy at “Dr. José Eleuterio González” University Hospital of 
the Universidad Autónoma de Nuevo León (UANL), Mexi- 
co. The patients agreed to participate in the study by sig-
ning an informed consent form. We obtained demographic 
variables such as age, weight and relevant background. Pa-
tients were divided into 2 groups; in Group 1 infiltration 
with ropivacaine 7.5% (20 ml) was applied prior to closure of 
the surgical wound, while in Group 2 ropivacaine 7.5% (20 
ml) was instilled into the surgical wound. Inclusion criteria 
required patients to be between 20 and 60 years of age, to 
have a weight between 110 and 198 lb (50-90 kg), ASA I or II, 
to be scheduled for radical mastectomy, and have preopera-
tive test results within normal limits. Patients with a history 
of coagulopathy, radiotherapy, neurological alterations, and 
previous analgesic or antiinlammatory treatment were ex-
cluded. Subsequently, we assessed blood pressure, heart 
rate, respiratory rate, and pain using a visual analogue scale 
(VAS) in both groups; in addition the presence of nausea 
and/or vomiting was measured from 0 to 30 minutes posto-
peratively and 2, 4, 8, and 12 hours afterwards.
Data was inputted into a database created in Excel® 2010 
and analyzed using IBM® Statistic 21; for the quantitative varia-
bles, traditional descriptive statistics, measures of central ten-
dency, dispersion and position, as well as the observed 
frequencies in the qualitative variables were calculated. The 
values were veriied by group through hypothesis tests for me-
dian and proportion, according to each variable type (quanti-
tative and qualitative respectively) with a reliability of 95%.
Results
Average age was 49.7 ± 7.8 years for Group 1 (iniltration) 
and 43.8 + 12.5 years in Group 2 (instillation); there was no 
signiicant difference in both groups (p = 0.2234). Average 
weight was 71.4 kg ± 9.7 for Group 1, and 65.4 ± 14.3 for 
Group 2; we did not ind signiicant differences between the 
groups (p = 0.2863). 
Regarding ASA classiication, 50% of the patients in Group 
1 and 60% in Group 2 presented with ASA I; the rest of the 
patients in both groups were ASA II. We did not observe a 
statistically signiicant difference regarding vital signs in 
either group (Tables 1 and 2). No presence of nausea 
in either group was observed. 
Table 1 Systolic blood pressure comparison in both groups.
 
N = 20
Baseline  
Mean (SD)
30 min 
Mean (SD)
2 hours 
Mean (SD)
4 hours 
Mean (SD)
8 hours 
Mean (SD)
12 hours 
Mean (SD)
Group 1
n = 10
128.70 (24.10) 124.80 (15.50) 125.80 (12.49) 124.10 (13.99) 120.70 (13.28) 120.50 (13.44)
Group 2
n = 10
126.40 (16.41) 120.00 (20.63) 121.50 (19.26) 123.10 (16.46) 117.80 (12.95) 119.20 (13.09)
p NS NS NS NS NS NS
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Regarding the VAS results, Group 2 showed better re-
sults in all of the evaluation periods, except at 12 hours 
when results were better in Group 1; however, such diffe-
rences did not prove to be statistically signiicant (Fig. 1). 
A higher number of rescue medication (dexketoprofen 50 
mg intravenously [IV]) for Group 1 at 30 minutes and 4 
hours was required. In addition, 1 patient from Group 1 
required buprenorphine as rescue medication, as she fai-
led to show a decrease in pain. Neither group showed side 
effects.
Discussion 
When cross-referencing both groups, no differences were 
seen; in both cases the behavior of the variables was the sa- 
me statistically, mainly concerning pain, except for the group 
managed with iniltration requiring rescue medication. Despi-
te advances in the knowledge of pain and the constitution of 
Algology as a new specialty, postoperative pain is frequent in 
patients after a surgical procedure; if avoided; side effects 
may be prevented.15-18
Most clinical research studies on preventive analgesia in 
patients who undergo radical mastectomy refer to spinal 
blocks. Epidural anesthesia has also been evaluated as 
anesthesia and management of acute pain during the per-
formance of the mastectomy; yet in the present study we 
decided not to use it for anesthetic purposes, given the 
fact that it must be placed in the metamers between C 
VII y D IV. The puncture of the intervertebral spaces in 
this region is technically dificult and the position the pa-
tient must assume in order to place it may increase the 
anxiety that involves a morbidity risk due to ventilation 
problems; this increases if there is a need to sedate the 
patient.19 
Iniltration of the wound and instillation of local anesthe-
tics is another simple and effective technique providing 
pain relief during the early postoperative period follo- 
wing surgical procedures. There are studies indicating that 
ropivacaine iniltration on the surgical wound after surgery 
reduces pain intensity, reducing the requirement of posto-
perative analgesics and inpatient days. In addition, the 
amount of applied anesthetics and its absorption through 
the peritoneal surface provide an additional mechanism of 
analgesia. 
Multiple studies have been performed in order to demons-
trate the clinical safety of ropivacaine in animals as well as 
in humans (5 mg/ml IV infusions).19 The literature reports 
few studies on instillation and infiltration of ropivacaine 
7.5%; thus, having found similar results with this route of 
administration in the present study, it is recommended as 
an alternative for optimal postoperative analgesia in pa-
tients who undergo radical mastectomy. Incidence of nausea 
and vomiting, if any, is low.
We found that ropivacaine iniltration or instillation in 
the surgical wound prior to skin closure showed no signii-
cant difference on postoperative pain (except for the 
necessity of using rescue medication in the infiltrated 
analgesic group); this was proven when cross-referencing 
VAS recordings at 2, 4, 8 and 12 postoperative hours bet-
ween each group (p > 0.05 in every crossing); however, 
when looking at the numerical behavior, lower values of 
pain in the “iniltration” group were found. Nevertheless, 
this could also be caused by the use of rescue medications; 
in addition, the patient’s resistance to the analgesic can 
also be a variable presented at random. Consequently, the 
use of a larger sample for future related studies should be 
the next step, with the purpose of increasing the statisti-
cal value in search of establishing whether or not there is 
a signiicant difference.
Table 2 Diastolic blood pressure comparison in both groups.
 
N = 20
Baseline 
Mean (SD)
30 min 
Mean (SD)
2 hours 
Mean (SD)
4 hours 
Mean (SD)
8 hours 
Mean (SD)
12 hours 
Mean (SD)
Group 1
n = 10
73.10 (14.12) 69.20 (9.94) 73.20 (7.21) 77.60 (9.51) 71.60 (9.87) 71.70 (9.61)
Group 2
n = 10
72.10 (8.02) 70.50 (15.41) 72.80 (11.89) 71.80 (7.90) 72.20 (10.70) 70.90 (7.99)
p NS NS NS NS NS NS
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Figure 1 Visual analog scale.
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Conclusions
No statistical difference was found between the use of ropi-
vacaine 7.5% iniltrated or instilled in patients undergoing 
radical mastectomy.
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